Targeting MET in NSCLC: An Ever-Expanding Territory
JTO CLINICAL AND RESEARCH REPORTS（2024）
Key words
MET,Tyrosine kinase inhibitor,Monoclonal anti- bodies,Antibody-drug conjugate,Non-small cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined